Candel Therapeutics stock jumps as pancreatic cancer treatment shows promise

Shares of Candel Therapeutics climbed early Friday after the company released new data on its experimental cancer treatment.

Previous post Bank of America’s paper loss on its bond portfolio reaches $110 bln and outpaces other banks: report
Next post SoFi’s stock has faced very negative sentiment, but that seems to be softening